Kaiser Health News
MARCH 15, 2023
“We had a massive opioid problem that needed to be rectified,” said Antonio Ciaccia, president of 3 Axis Advisors , a consulting firm that analyzes prescription drug pricing. “But the federal crackdowns and guidelines have created collateral damage: patients left high and dry.”
Kaiser Health News
MARCH 15, 2023
“We had a massive opioid problem that needed to be rectified,” said Antonio Ciaccia, president of 3 Axis Advisors , a consulting firm that analyzes prescription drug pricing. “But the federal crackdowns and guidelines have created collateral damage: patients left high and dry.”
Hall Render
FEBRUARY 18, 2022
License wait times reach crisis levels for healthcare workers. Meet new FDA chief Dr. Robert Califf: 5 things to know. Only 14% of Hospitals Met Price Transparency Rule Compliance. Bill on prescription drug pricing inspires support from Maine residents, opposition from pharmaceutical industry.
Expert insights. Personalized for you.
88 
Let's personalize your content